I’ve wanted to report on this for a couple of weeks now but needed to wait for further developments.
If any readers remember, I reported on India’s COVID-19 situation a few months ago.
January 18th to be exact.
India developed a Home COVID-19 Treatment Kit for $3 per person.
The kit contained Zinc, Doxycycline, and Ivermectin.
Back in January, India’s COVID-19 situation was tame compared to other parts of the world.
According to Worldometer, India reported 9,975 new COVID-19 cases on January 18th, 2021.
On April 30, 2021, India reported 402,110 new COVID-19 cases.
Here’s the latest on India’s dire situation:
New cases in India have surpassed 400,000—the highest caseload yet. Even that is sure to be an underestimate https://t.co/x6kI3wlTGr
— The Economist (@TheEconomist) May 4, 2021
BREAKING: India reports 382,602 new coronavirus cases and a record high 3,783 new deaths
— J&K Blood Donors Volunteers 🇮🇳 (@JK_Blood_Donors) May 4, 2021
A court in India's capital New Delhi has become the last hope for many hospitals struggling to get oxygen for COVID-19 patients as supplies run dangerously short. https://t.co/7H1EWwdXi5
— SBS News (@SBSNews) May 4, 2021
'Horrible' weeks forecast for India as the COVID catastrophe worsens https://t.co/xZ3pbO8pvw pic.twitter.com/gQboKAjOrX
— TIME (@TIME) May 4, 2021
So, what caused India to take such a drastic downturn with COVID-19?
The answer may lie with Big Pharma and the desire to vaccinate the global population with experimental vaccines.
I don’t understand how people can watch this images from India of Covid patients suffocating to death and refuse a life-saving vaccine.
— Jim Sciutto (@jimsciutto) May 4, 2021
Pfizer in talks with India for COVID-19 vaccine https://t.co/kBn3GNyMrO by @AnjKhem pic.twitter.com/68ErZye9Fc
— Yahoo Finance (@YahooFinance) May 4, 2021
Suspiciously, India became much less reliant on the affordable home treatment kit when starting their COVID-19 vaccine rollout.
Life Site News added commentary:
Virtually every news outlet has been screaming about the incredibly high rates of COVID victims, hospitalizations and deaths in India. Missing in these countless stories is awareness that the cause of the COVID surge could be connected to the reduced use in India of two proven generic drugs for treating and preventing COVID: first it was hydroxychloroquine and later ivermectin.
As a proponent of using these two medicines I have reviewed the strong real world data showing their effectiveness to cure and prevent COVID in Pandemic Blunder. Anyone honestly following the science would have to conclude that both of these medicines really work.
During 2020 and the first months of this year the COVID pandemic in India by all accounts was not at all devastating. And careful examination of the good news was that those two generic medicines had been widely provided to the population. Then the COVID vaccine movement hit the world and the terrible COVID surge hit India.
The mainstream media waged a war against early home/outpatient COVID treatment successfully used globally with those two generic medicines, both with very long histories of safety. Now the same media finds it appropriate to focus attention on all the bad news in India. But why have the media ignored the evidence that the India surge could be connected to the government dropping its wide use of ivermectin in recent months?
Why would this happen? Certainly, all the negative media coverage of ivermectin could have caused the India government to switch its priority to vaccines. If so, it has proven to be a blunder of epic proportions with many hundreds of thousands of Indians suffering and dying.
Sadly, it is difficult to find substantial interest in examining the possible role of reduced use of ivermectin in these dark days of the COVID pandemic in India.
Here are several key articles. First, an April 14 article “Doctor Believes Ivermectin Drug Can Help India Stop Covid-19 Second Wave” in the India Times talked about Dr. Surya Kant Tripathi, Head of Respiratory Medicine Department at King George Medical University in Lucknow. He believes ivermectin “could help take control over the novel coronavirus.” Also noted was that ivermectin “is now being commonly used in various states in India.”
This senior physician also noted this about ivermectin use: “This drug is now being commonly used in various states in India.” This too was noted: “Indian medical institutions have started giving COVID-19 patients Ivermectin off-label. Medical institutions across the nation are also giving the drug as a prophylaxis against the novel coronavirus. This is being seen in several states of the nation including Uttar Pradesh and Maharashtra. Dr. Tripathi, in a conversation with Financial Express revealed that the drug has been in use for over nine months now without major side effects being reported.”
Did Big Pharma’s influence steer India towards this downward spiral by directing the country away from effective and affordable at-home treatment kits?
Tell us your thoughts.
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!